|
Urology Research
Research has always
been an important focus of the Division of Urologic Surgery
at Washington University School of Medicine.
From the earliest days, there
has been an understanding that an effective doctor must be a good scientist
as well as a compassionate and understanding person. In keeping with that
principle, the division’s surgeons continually undertake research projects
that are at the forefront of urologic research on topics such as prostate
cancer screening, treatment of benign prostate enlargement, the genetics
of urologic malignancies, the male reproductive system, cellular research
and pediatric urology.
In the area of prostate cancer
screening, the division is participating in the Prostate, Lung, Colon and
Ovarian (PLCO) Cancer Screening Trial, which is funded by the National Institutes
of Health (NIH) and National Cancer Institute (NCI). Dr. Gerald L. Andriole,
Jr., chief of the Division of Urologic Surgery, is chairman of the Prostate
Subcommittee for the trial, which is expected to be the definitive study
addressing the benefits of screening for prostate, lung, colon and ovarian
cancer. In addition to the PLCO trial, Dr. Andriole is involved in a clinical
trial evaluating the drug dutasteride as a chemo-preventative agent for
prostate cancer.
Other key areas
of research by division urologists include:
- How precancerous cells or cancer cells respond to conditions of low
oxygen or reduced nutrients (with implications for prostate cancer)
- The genetics of urologic malignancies
- Varied aspects of urinary incontinence
Learn more
about:
Washington University physicians are the medical staff of
Barnes-Jewish Hospital and St. Louis Children's Hospital
|
